As more efforts are being made to develop drug delivery technologies for self-administration, it becomes paramount to ensure that these therapies make sense within the workflow of patients and ...
On-body delivery systems for subcutaneous isatuximab could enable patient self-administration, according to Xavier Leleu, MD, PhD, improving convenience and transforming treatment for ...
Credit: Apellis The Empaveli Injector is expected to be available by the end of October. The Food and Drug Administration (FDA) has approved a single-use, disposable, on-body injector for ...
WILMINGTON, Del.--(BUSINESS WIRE)--Positive high-level results from a pre-specified interim analysis of the Phase III TULIP-SC trial in patients with systemic lupus erythematosus (SLE) showed that the ...
AstraZeneca’s (AZN) Saphnelo has been approved in the European Union, EU, for subcutaneous self-administration as a pre-filled pen for adult patients with systemic lupus erythematosus, SLE, on top of ...
(Alliance News) - AstraZeneca PLC on Tuesday said its drug Saphnelo, or anifrolumab, has been approved in the European Union as a new pre-filled pen for systemic lupus erythematosus. The Cambridge, ...
The subcutaneous administration of granisetron, an antiemetic pharmaceutical drug (suitable for control of vomiting), achieves similar blood concentrations to those administered intravenously. This ...
The TULIP-SC trial evaluated the efficacy and safety of the subcutaneous administration of SAPHNELO compared to placebo in participants with moderately to severely active, autoantibody-positive SLE, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results